Organization
Cutia Therapeutics (Wuxi)
6 clinical trials
Clinical trial
A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of CU-20401 for Injection in Moderate to Severe Contour Protuberance or Excessive Enrichment Due to Submental Fat (SMF) AccumulationStatus: Recruiting, Estimated PCD: 2024-07-08
Clinical trial
A Phase III Clinical Study of the Efficacy and Safety of Lidocaine and Tetracaine Cream (CU-30101) in a Multicenter, Randomized, Double-Blind, Active-Controlled, Paired Design for Facial Laser Aesthetics in Chinese AdultsStatus: Not yet recruiting, Estimated PCD: 2023-08-12
Clinical trial
A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Finasteride Spray (CU-40102) in Chinese Adult Male Patients With Androgenetic Alopecia (AGA)Status: Completed, Estimated PCD: 2023-03-07
Clinical trial
A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia SubjectsStatus: Recruiting, Estimated PCD: 2023-11-01
Clinical trial
A Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of a Single Subcutaneous Injection of CU-20401 in Chinese Healthy PopulationStatus: Recruiting, Estimated PCD: 2023-07-30
Clinical trial
a Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401 Administered Subcutaneously in the Submental Fat (SMF) PopulationStatus: Completed, Estimated PCD: 2022-12-30